<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on two prepubescent girls with <z:hpo ids='HP_0000572'>visual loss</z:hpo> due to idiopathic intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (IIH), or <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, both treated with recombinant human growth hormone for <z:hpo ids='HP_0001510'>growth failure</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The interval from starting hormone therapy to diagnosis of IIH was 3 and 18 months, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Both girls did not complain of <z:hpo ids='HP_0002315'>headache</z:hpo> and <z:hpo ids='HP_0002018'>nausea</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>They were neither <z:mp ids='MP_0001261'>obese</z:mp> nor did they suffer from <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In both patients, we observed bilateral optic disc <z:hpo ids='HP_0000969'>edema</z:hpo> with <z:hpo ids='HP_0000572'>visual loss</z:hpo> and elevated cerebrospinal fluid (CSF) pressures </plain></SENT>
<SENT sid="5" pm="."><plain>Other causes of IIH were excluded with neuroimaging and CSF examination </plain></SENT>
<SENT sid="6" pm="."><plain>Cessation of drug administration is often sufficient for symptom resolution in cases of hormone therapy-associated IIH </plain></SENT>
<SENT sid="7" pm="."><plain>However, <z:hpo ids='HP_0001123'>visual field defects</z:hpo> in one girl remained unchanged during follow-up of 8 months </plain></SENT>
<SENT sid="8" pm="."><plain>In children with IIH, the spectrum of neurologic and visual manifestations might be variable and unspecific </plain></SENT>
<SENT sid="9" pm="."><plain>Diagnosis and management of IIH can be difficult in the absence of <z:hpo ids='HP_0002315'>headache</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Blurred or <z:hpo ids='HP_0000651'>double vision</z:hpo> due to <z:hpo ids='HP_0006824'>cranial nerve palsy</z:hpo> might be the only symptom rather than complaints about <z:hpo ids='HP_0000505'>reduced visual acuity</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, regular clinical monitoring of visual function and fundus appearance is essential for early diagnosis, efficient management, and improvement of visual outcome in children receiving recombinant human growth hormone </plain></SENT>
</text></document>